ACHE and early-onset autosomal dominant Alzheimer disease: Pharmacological studies, in vitro, conducted in the search for novel drugs which would improve the symptoms of Alzheimer’s disease (AD), have demonstrated that both compounds are potent and reversible acetylcholinesterase (AChE) inhibitors which cross the blood-brain barrier [5,6].